Development of a telemedicine network for early oral cancer diagnosis: the Argentine Patagonia experience-a perspective through a pilot study

Abstract

Geographic areas like Argentine Patagonia face significant barriers in the fight against oral cancer due to great distances, extreme weather conditions, and a shortage of specialists. These factors contribute to delayed diagnosis and treatment, adversely affecting patient outcomes. The aim of this study was to describe a pilot project to establish the telemedicine network of Chubut (Argentine Patagonia) for the early diagnosis of oral cancer. This perspective study also aimed to describe the advantages and disadvantages of using this tool in remote areas with limited access to healthcare services. Healthcare professionals, including nurses, dentists, doctors, and healthcare workers, were trained in the early diagnosis of oral cancer and high-risk oral lesions by five specialists in Oral Medicine, who traveled throughout Argentine Patagonia. Additionally, training was provided on the use of smartphones to obtain clinical images and data for remote consultations via telemedicine with a specialized center. Over 2,000 km were traveled, and more than 100 healthcare professionals were trained in six towns and localities in Patagonia, Argentina, encountering various limitations for the use of telemedicine in remote areas, such as connectivity issues. The first telemedicine network of Patagonia for the diagnosis of oral cancer was created and is now operational, receiving teleconsultations and referrals from the professionals trained during the journey. This study highlighted that telemedicine is an important tool to overcome geographical barriers and improve access to medical care, especially in remote areas. It promotes agility and speed in referrals and optimizes the available resources of the health system. Future studies should analyze the impact of telemedicine in decreasing the delay of oral cancer diagnosis in Southern Argentina.

Keywords

Oral cancer / telemedicine / Patagonia

References

[1] Martínez-Ramírez J, Saldivia-Siracusa C, González-Pérez LV, Cuadra Zelaya FJM, Gerber-Mora R, Cabrera OFG, et al. Barriers to early diagnosis and management of oral cancer in Latin America and the Caribbean. Oral Dis. 2024;[Online ahead of print].

[2] Mohammadzadeh N, Rezayi S, Saeedi S. Telemedicine for Patient Management in Remote Areas and Underserved Populations. Disaster Med Public Health Prep. 2022; 17:e167.

[3] Villa A, Sankar V, Shiboski C. Tele(oral)medicine: A new approach during the COVID-19 crisis. Oral Dis. 2021; 27:744-5.

[4] Gillligan GM, Piemonte ED, Lazos JP, Panico RL. In reply to the letter to the editor “Tele(oral)medicine: A new approach during the COVID-19 crisis”. Oral Dis. 2021; 27:764-5.

[5] Morelatto RA, Moretti C, Bolesina NJ, Zapata MJ, Liandro MF, Warnakulasuriya S, et al. Reexamination of delays in diagnosis of oral cancer following an intervention program in Cordoba, Argentina. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022; 133:301-7.

[6] Cardozo I, da Silva VC, Perdoncini NN, Torres-Pereira CC. Telehealth in Oral Medicine: report of an experience from public health care in a southern Brazilian state. Braz Oral Res. 2022; 36:e031.

[7] Carrard VC, Roxo Gonçalves M, Rodriguez Strey J, Pilz C, Martins M, Martins MD, et al. Telediagnosis of oral lesions in primary care: The EstomatoNet Program. Oral Dis. 2018; 24:1012-9.

[8] Birur PN, Sunny SP, Jena S, Kandasarma U, Raghavan S, Ramaswamy B, et al. Mobile health application for remote oral cancer surveillance. J Am Dent Assoc. 2015; 146:886-94.

[9] Santos-Silva AR, Martínez-Ramírez J, Lopes MA. Addressing discrepancies in oral cancer reporting: GLOBOCAN estimates versus ground reality in Latin America and the Caribbean. Cancer Epidemiol. 2024; 88:102498.

[10] Piemonte ED, Lazos JP, Belardinelli P, Castillo GDV, Talavera AD, Secchi DG, et al. Effect of the accumulation of risk factors on the risk of oral squamous cell carcinoma. Rev Fac Cien Med Univ Nac Cordoba. 2021; 78:158-65. Spanish.

[11] Northridge ME, Weiserbs KF, Sabounchi SS, Torroni A, Mohadjeri-Franck NS, Gargano S, et al. A feasibility and acceptability study of using an intra-oral camera and an asynchronous tele-mentoring protocol to detect and identify oral lesions. J Public Health Res. 2022; 11:22799036221115778.

[12] Warnakulasuriya S, Kerr AR. Oral Cancer Screening: Past, Present, and Future. J Dent Res. 2021; 100:1313-20.

[13] Gupta A, Sonis S, Uppaluri R, Bergmark RW, Villa A. Disparities in Oral Cancer Screening Among Dental Professionals: NHANES 2011-2016. Am J Prev Med. 2019;57:447-57.

[14] Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int J Environ Res Public Health. 2020; 17:9160.

[15] Aapro M, Bossi P, Dasari A, Fallowfield L, Gascón P, Geller M, et al. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer. 2020; 28:4589-612.

[16] Almubarak H. The Potential Role of Telemedicine in Early Detection of Oral Cancer: A Literature Review. J Pharm Bioallied Sci. 2022; 14:S19-23.

[17] Roine R, Ohinmaa A, Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ. 2001; 165:765-71.

[18] Kunin M, Julliard KN, Rodriguez TE. Comparing face-to-face, synchronous, and asynchronous learning: postgraduate dental resident preferences. J Dent Educ. 2014; 78:856-66.

[19] Gurushanth K, Sunny SP, Raghavan SA, Thakur H, Majumder BP, Srinivasan P, et al. Holistic Approach for the Early Detection of Oral Cancer: A Comprehensive Training Module. J Maxillofac Oral Surg. 2024; 23:816- 23.

[20] Haron N, Zain RB, Nabillah WM, Saleh A, Kallarakkal TG, Ramanathan A, et al. Mobile Phone Imaging in Low Resource Settings for Early Detection of Oral Cancer and Concordance with Clinical Oral Examination. Telemed J E Health. 2017; 23:192-9.

[21] Haron N, Rajendran S, Kallarakkal TG, Zain RB, Ramanathan A, Abraham MT, et al. High referral accuracy for oral cancers and oral potentially malignant disorders using telemedicine. Oral Dis. 2023; 29:380-9.